Kane Biotech

We're pleased to announce that Kane Biotech's revyve™ Antimicrobial Wound Gel has been approved by Health Canada as a Class 2 Medical Device! 🙌

This is a huge achievement, and it wouldn't have been possible without the hard work of our dedicated team. We're excited to make revyve™ available to Canadians, bringing advanced wound care to those who need it most!

👉 Read the full article: https://www.globenewswire.com/news-release/2024/11/14/2981511/0/en/Kane-Biotech-Announces-Health-Canada-Approval-of-revyve-Antimicrobial-Wound-Gel.html

Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that...

Thank you to the Winnipeg Free Press for featuring Kane Biotech’s commitment to making a positive impact through our donation of 2,000 ounces of revyve™ Antimicrobial Wound Gel to the Ukrainian medical relief effort. (Please note, the article mistakenly mentions 20,000 ounces; the correct amount is 2,000 ounces.)

👉 Read the full article: https://winnipeg-can.newsmemory.com/?publink=09739fd1c_134d4a4
👉 Read Kane’s full press release: https://ir.kanebiotech.com/press-releases/detail/383/kane-biotech-announces-donation-of-revyve-antimicrobial

Kane Biotech donates antimicrobial wound gel to Ukrainian war efforts MARTIN CASHKANE Biotech is donating up to 20,000 ounces of its antimic

Kane Biotech will be donating 2,000 ounces of our revyve™ Antimicrobial Wound Gel to aid in the Ukraine medical relief effort. Our goal is to make our product accessible to the people of Ukraine suffering from chronic wounds, in the hopes that we can do our part in helping to heal the many Ukrainian casualties.

Read the full press release: https://ir.kanebiotech.com/press-releases/detail/383/kane-biotech-announces-donation-of-revyve-antimicrobial